20th October, 2014

New board will address compliancy of the firm’s OTC derivatives solutions
Access this article plus the full FOW Intelligence platform, featuring timely insights, expert analysis, and comprehensive volumes data from 100+ exchanges. Everything you need to make informed decisions.
Already have an account?Log in
